Manolo D’Arcangelo
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 21
- Prostate Cancer Treatment and Research 2
- Renal cell carcinoma treatment 2
- Oncology 12
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 4
- Cancer Cells and Metastasis 1
- Co-authors
- Federico Cappuzzo (16 shared papers)Fred R. Hirsch (1 shared paper)Lorenza Maria Landi (12 shared papers)Armida D’Incecco (6 shared papers)Alfredo Falcone (2 shared papers)Paola Orlandi (2 shared papers)Anna Fioravanti (2 shared papers)Luca Galli (2 shared papers)
- Journals
- Annals of Oncology (7 papers)Journal of Thoracic Oncology (5 papers)Oncotarget (2 papers)New England Journal of Medicine (2 papers)Future Oncology (2 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Manolo D’Arcangelo
36 papers receiving 1.1k citations
Manolo D’Arcangelo's Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 407
- Pulmonary and Respiratory Medicine 539
- Cancer Research 52
- Otorhinolaryngology 13
- Biotechnology 16
Countries citing papers authored by Manolo D’Arcangelo
This map shows the geographic impact of Manolo D’Arcangelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manolo D’Arcangelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manolo D’Arcangelo more than expected).
Fields of papers citing papers by Manolo D’Arcangelo
This network shows the impact of papers produced by Manolo D’Arcangelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manolo D’Arcangelo. The network helps show where Manolo D’Arcangelo may publish in the future.
Co-authors
The 25 scholars most cited alongside Manolo D’Arcangelo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial Hit paper breakdown → | 2020 | 367 |
| 2 | Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC Hit paper breakdown → | 2024 | 262 |
| 3 | 2009 | 78 | |
| 4 | 2022 | 56 | |
| 5 | Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC Hit paper breakdown → | 2025 | 45 |
| 6 | 2013 | 36 | |
| 7 | 2010 | 28 | |
| 8 | 2014 | 28 | |
| 9 | 2018 | 25 | |
| 10 | 2012 | 24 | |
| 11 | 2013 | 21 | |
| 12 | 2019 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2013 | 16 | |
| 15 | 2015 | 14 | |
| 16 | 2014 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2016 | 11 | |
| 19 | 2019 | 11 | |
| 20 | 2022 | 11 |
About Manolo D’Arcangelo
Manolo D’Arcangelo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pharmacology, Statistics and Probability and Cancer Research, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (4 papers), Prostate Cancer Treatment and Research (2 papers), Renal cell carcinoma treatment (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Cancer Genomics and Diagnostics (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Oncology (407 citations), Pulmonary and Respiratory Medicine (539 citations), Cancer Research (52 citations), Otorhinolaryngology (13 citations) and Biotechnology (16 citations). Manolo D’Arcangelo has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Federico Cappuzzo, Fred R. Hirsch, Lorenza Maria Landi, Armida D’Incecco, Alfredo Falcone, Paola Orlandi, Anna Fioravanti, Luca Galli, Guido Bocci and Romano Danesi. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Oncotarget, New England Journal of Medicine and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.